which has demonstrated a potentially best-in-class safety profile and is designed to allow the LNP to access liver cells using either the low-density lipoprotein receptor (LDLR) or the ...

PCSK9 (proprotein convertase subtilisin/kexin 9) increases low-density lipoprotein (LDL)-cholesterol levels via LDL receptor (LDLR) degradation. The role of PCSK9 in macrophage activation and vein ...

Department of Biochemistry and Molecular Biology, Hengyang Medical School, University of South China. (X.Z., S.L., M.Z., C.Z.) Center for Precision Medicine and ...